Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Twice daily
MoneyWeek
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Four times a week
Look After My Bills
Sign up to our free money-saving newsletter, filled with the latest news and expert advice to help you find the best tips and deals for managing your bills. Start saving today!
Hi-tech tool manufacturer Oxford Instruments said first half pre-tax profit fell to £12.5m from £13.2m the year before but sees an improved second half.
The group, which makes and supplies tools and systems with a focus on research and industrial applications, said revenue surged over 40% in a 'robust' market environment and as it introduced new products.
Revenue for the six months to 30 September 2011 rose 41% to £159m with organic growth of 30%. Adjusted profit before tax rose to £18.7m from £10.6m before.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Order intake rose 24% to £175m in the six-month period. Oxford saw continued growth in China with orders up 53%.
Chairman Nigel Keen said, "Our broad spread of geographies and technologies, and our strong pipeline of new products should help us to remain resilient in the event of a global economic downturn. We are continuing our active pursuit of acquisitions that have the potential to enhance shareholder value and add to our range of technical capabilities."
"Trading since the period end has remained strong and the Board believes that performance in the second half of the year is likely to exceed that of the first half," he added.
The company, which recently bought US medical firm Platinum Medical Imaging, said its acquisitions of Omicron NanoTechnology and Omniprobe in June are integrating well and performing to plan.
The interim dividend has been lifted 10% to 2.77p.
--
cj
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
How a ‘great view’ from your home can boost its value by 35%A house that comes with a picturesque backdrop could add tens of thousands of pounds to its asking price – but how does each region compare?
-
What is a care fees annuity and how much does it cost?How we will be cared for in our later years – and how much we are willing to pay for it – are conversations best had as early as possible. One option to cover the cost is a care fees annuity. We look at the pros and cons.
